Navigation Links
EvoNexus company PhageTech closes $2.4 million Series A financing for commercialization of one- minute blood and urine test.

IRVINE, Calif., Oct. 1, 2015 /PRNewswire-USNewswire/ -- EvoNexus Irvine company PhageTech, Inc. announced that it has raised $2.4 million in Series A funding from a group of early stage investors co-led by Mark IV Capital and Black River Investments. The funding will be used to complete development and FDA clearance of its revolutionary PhageTech BioSensor™ technology.

EvoNexus is the leading startup technology incubator in Southern California with locations in San Diego and Irvine. It has the largest network of entrepreneurs, mentors, tech industry leaders, and investors in the region.

"EvoNexus is always looking for startups developing technological breakthroughs, and PhageTech's biosensor technology certainly qualifies," says EvoNexus CEO Rory Moore. "By being able to accurately detect certain types of early stage cancers and other diseases PhageTech technology will enable potential treatments that may produce better outcomes for the patient through early detection and lower healthcare costs for treatments required in later stage cancer patients." PhageTech is a great example of the partnership being formed with the University of California, Irvine, and EvoNexus.

The closest thing to a cure for cancer is early detection. PhageTech Biosensors will enable early detection of cancers and other diseases while making disease detection instantaneous, simpler, affordable, near patient and readily accessible world-wide.

CEO Richard Henson states, "Our technology enables an entire new category of near patient testing with tremendous benefits in portability, simplicity, time to result and cost over the current standard in lab- based diagnostics (e.g. sending samples out to a lab and waiting for results). The entire diagnostic test is contained in a chip the size of a postage stamp without compromising accuracy, enabling physicians to make instant treatment decisions.

"Our vision is to develop PhageTech Biosensors and readers for physicians as well as patients (e.g. through an app on a cell phone). It will especially have enormous implications for developing countries with minimal resources who are in need of simple, low cost, near patient testing. Our goal in 10 years is to touch over one billion people."

Developed with NIH funds at the University of California, Irvine, the PhageTech Biosensors will be interfaced with portable readers enabling inexpensive, quantitative, near patient testing in under one minute providing physicians with real-time valuable information for quicker diagnoses, treatment and improved patient outcomes.

About PhageTech:
PhageTech, Inc. is developing a transformative medical diagnostics platform that will enable immediate, near patient, and affordable disease testing worldwide, improving health, lowering costs and saving patient lives. Our vision is that in 10 years, we will have positively touched the lives of over a billion people.

For more information, visit

About EvoNexus:
EvoNexus is a technology incubator for Southern California's startup and entrepreneurial community with locations in San Diego and Irvine. EvoNexus empowers motivated entrepreneurs to turn their transformative ideas into fundable, commercially viable companies, and leverages community resources to provide what entrepreneurs need to be successful. EvoNexus has three locations across Southern California thanks to the Irvine Company's dedication to entrepreneurship and the innovation economy.

For more information, visit

Media Contacts:
Arlene Bumb
Vice President Marketing and Business Development

Carolyn Liikala
Program Manager, Irvine

Chris Norris
Communications & Marketing Manager, San Diego & Irvine



Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Regen BioPharma, Inc. Director of Molecular Therapeutics to Speak at Stem Cell Conference Regarding Leukemia Research Being Conducted by the Company
2. Entest BioMedical Updates Company Status and Future Plans
3. Russian Company Semiotik Comes Into Indian Market of Microchips for Assay of Blood and Donor Plasma
4. Perrigo Company To Present At The Morgan Stanley 2015 Global Healthcare Conference
5. Mindray Announces Receipt of Revised Non-binding Proposal to Acquire the Company at US$27 per ADS or US$27 per Ordinary Share
6. Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering
7. VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa
8. Elekta to Host Cancer Survivorship Event at Companys Learning and Innovation Center (LINC) in Atlanta
9. AccuTec Blades, Inc. Announces Acquisition of Industrial Blades Division from Edgewell Personal Care Company
10. Patterson Medical Positioned for Continued Growth as a Newly Independent Company
11. IP Shakti, LLC Changes Company Name to Prediqtus, LLC
Post Your Comments:
(Date:7/17/2019)... ... ... Soliant, a leading healthcare staffing provider and part of the Adecco Group, ... Beautiful Hospital in the U.S. In Soliant’s 10th annual top 20 contest, a record ... hospitals nominated. Supporters from across the country nominated and voted for facilities they felt ...
(Date:7/17/2019)... ... July 17, 2019 , ... The ... CME subsidiaries: Global Learning Collaborative (GLC). , “The past few years ... subsidiaries, scientific teams, leadership, and educational collaborations,” said Rob Braun, President of GLC. ...
(Date:7/17/2019)... ... 17, 2019 , ... Eargo the direct-to-consumer health tech company destigmatizing ... three new executive hires: CFO Adam Laponis (from Tesla, Inc.), CMO Shiv Singh (from ... Apple, Inc.). , The new hires come on the heels of Eargo’s ...
Breaking Medicine Technology:
(Date:7/17/2019)... ... July 17, 2019 , ... The Blackboard Catalyst Award ... Practitioner program. The honor is given to distance learning courses and programs that ... Awards honor institutions from around the world that produce exemplary educational and training ...
(Date:7/17/2019)... ... July 17, 2019 , ... ICD10monitor, ... the ICD-10 coding set, is launching an exclusive educational webcast subscription service featuring ... additional charge, officials announced this week. , The ICD10monitor webcast portfolio already ...
(Date:7/17/2019)... ... July 17, 2019 , ... A new study led ... of the American Medical Association (JAMA), shows for the first time that New ... the state. Sepsis is the body’s extreme response to infection. It kills more than ...
(Date:7/17/2019)... ... 17, 2019 , ... Dr. Jonathan Zaidan, MD, FACOG, President of Women’s Excellence ... Show. The show airs on Wednesday, July 17ths at 7pm. The show ... and co-host Ann Thomas discuss the challenges that women face when it comes to ...
(Date:7/13/2019)... ... July 12, 2019 , ... Ospitek ... its proprietary patient management platform, Ospitek “View”. Ospitek has partnered with some of ... a fully customizable, intelligent, solution made specifically for surgical centers, allowing them to ...
Breaking Medicine News(10 mins):